Contraception Reproductive Physiology Flashcards
Most women have menstrual cycles lasting 24-35 days with an average of 28 days. The first day of blood flow is day 1 of the cycle. 20% of women experience irregular cycles. The normal menstrual cycle has 2 phases: The______ phase is variable lasting an average of 10-17 days while the_____ phase is more constant at 14 days.
follicular
luteal
Hypothalamic GnRH is secreted in a pulsatile fashion every 60-90 minutes and travels via the portal circulation to the anterior pituitary to produce
LH and FSH
promotes ovarian follicular growth by causing granulosa cells that line each follicle to proliferate and **produce estradiol **
FSH
promotes androgen production in theca cells adjacent to the granulosa cells
LH
The_____ diffuse from the theca cells –> granulosa cells where they are converted by the enzyme aromatase to estrogen
androgens
FSH promotes ovarian ______to proliferate and secrete estradiol resulting in follicular growth
granulosa cells
As estradiol levels rise a positive feedback loop of rising LH stimulates increased estrogen resulting in greater pituitary secretion of
LH >> FSH
About 2 days prior to ovulation secretion of___ rises 6-10 fold
LH surge causes resumption of_____ in the dominant oocyte, luteinization of granulosa cells with increased progesterone and slowed estrogen synthesis
LH
meiosis
Follicular rupture occurs 32- 44 hours after onset of _____ and 10-12 hours after _____
LH surge
LH peak
Onset of the LH surge is the most reliable predictor of _____
During the luteal phase shift is to________ dominance which suppresses new follicular growth and causes secretory changes to the endometrium
ovulation
progesterone
If pregnancy does not occur the declines 9-11 days after ovulation with a drop in ______, ______, and ______ levels with resultant shedding of the endometrial lining, rise in FSH and LH, and development of a new follicle
progesterone, estrogen, and inhibin
After ovulation the oocyte retains potential for fertilization for ________
Sperm remain viable in the reproductive tract for up to _____
12- 24 hours
120 hours
Oocyte is swept into lumen of the fallopian tube by the fimbria
Fertilization occurs in the______ portion of the tube
ampullary
After fertilization the zygote reaches the uterine cavity by day ____and implantation begins day____ when embryo is at the blastocyst stage
4-5
5-7
Combined hormonal contraceptives, contraceptive implant, contraceptive injection
• Prevent ovulation
Abstinence, fertility awareness methods, intrauterine device, progestin only pill, barrier methods, spermicides, withdrawal, sterilization
• Prevent fertilization
Estrogen PLUS Progestin
– Three formations
What is the mechanism?
“ The Pill”, Transdermal patch, Vaginal ring
Prevent ovulation and Thicken cervical mucous
Prevention of Ovulation
- is the dominant hormone in CHC formulations
- diminishes frequency of hypothalamic GnRH pulse frequency
- inhibits the estrogen induced LH surge at mid-cycle
Progestin
suppresses FSH preventing selection and emergence of dominant follicle
Estrogen
OCP: Majority contain _______, few 50 mcg formulations with mestranol, one with estradiol valerate.
Progestins vary by pill formulation: Estranes - norethindrone (1st generation)
- norgestimate, desogestrel (3rd gen) Gonanes- norgestrel, levonorgestrel (2nd gen) Spironolactone analogue- drospirenone (4th gen)
ethinyl estradiol
suppression of ovulation, Flexible ring delivers 15 mcg ethinyl estradiol and 120 mcg etonogestrel (active metabolite of desogestrel)
Combined Contraceptive Vaginal Ring
• 20 cm2 patch delivers 20 mcg of _______and________
(active metabolite of norgestimate)
- One patch per week for 3 weeks then one patch free week.
- Less effective in women >90 kg
ethinyl estradiol and norelgestromin
Combined Hormonal Contraceptives
- _____ levels of pro-coagulant factors II, VII, VIII, X, and fibrinogen
- _____ anticoagulants protein S, anti- thrombin, and tissue factor pathway inhibitor
- Induce resistance to the natural anticoagulant activated protein C
Increase procoagulants
Decrease procoagulants
Contraindications to CHC
History of venous thromboembolic event (VTE), inherited or acquired thrombophilia
Postpartum – initial 3-6 weeks after delivery
History of myocardial infarction or coronary
artery disease
History of cerebrovascular accident
Cigarette smokers > age 35
Complicated diabetes, vascular disease
Contraindications to CHC
Severe hypertension BP > 160/100
Migraine with aura
Severe active liver disease, cirrhosis, history of hepatic adenoma
Personal history of breast or endometrial cancer
Undiagnosed abnormal uterine bleeding
Pregnancy
What three methods involve progestin only?
- Pills
- Injection
- Subdermalimplant